In today’s evolving pharmaceutical landscape, the search for new drug delivery systems (DDS) is of paramount importance to improving therapeutic outcomes. With cutting-edge solutions in the field of microneedle technology, Protheragen-ING is on the front lines in this field. As a certified ISO9001 supplier of pharmaceutical ingredients and specialty chemicals, Protheragen-ING keeps innovating to meet the latest market demand.
Utilizing micron-sized needles to administer drugs directly into the skin, the microneedle technology has become a revolutionary tech in the delivery of drugs. It is not only highly bioavailable, but also has low side effects. With Protheragen-ING’s microneedle technology, controlled drug delivery can be achieved using precise and efficient use of both hollow and solid structures made from any materials (silicons, metals or biodegradable polymers).
The use of microneedles in transdermal drug delivery is much better than other methods, such as hypodermic needles and topical creams. With microneedles drilling down into the stratum corneum, it’s less invasive and more painless than ever before for injecting vaccines, hormones and other medications.
Protheragen-ING can support customers in all phases of microneedle development. From concept to prototyping to manufacture, Protheragen-ING tailors its processes to the unique therapeutic requirements of different sectors. The firm provides various microneedle technology services, such as:
- Coated Microneedle Development: For drug protection and release control.
- Dissolving Microneedle Development: Biological alternatives that suck up into the skin and deliver the drug payload to the surface.
- Hollow Microneedle Development: Ideal for delivery of a liquid drug with a precise dose.
- Hydrogel Forming Microneedle Development: For longer term release applications.
- Solid Microneedle Development: Used for perforation and first drug infusion.
- Integrated Drug Delivery Solutions
Apart from microneedle services, Protheragen-ING is also deeply involved in several novel drug delivery systems.
- Oral Thin Films: Fast dissolving method to make patient’s compliance easy by giving easy to use.
- Microencapsulation Systems: Guarding actives and allowing for controlled release.
- Nanoparticle Development: Solubility enhancement, tissue specificity to get best result from treatment.
- Vesicular Systems Engineering: Liposomal and niosomal formulations with enhanced stability and release characteristics.
- Etc.
Protheragen-ING never stops tinkering with drug delivery systems. With a breadth of knowledge in formulation design, material choice, and process and manufacturing optimization, this company has become an unbeatable resource for pharma companies and research groups looking for new solutions to the challenges of today’s drug therapies.
About Protheragen-ING
As the field evolves, Protheragen-ING’s investment in R&D keeps it at the forefront of drug delivery technology. Its emphasis on improving the quality of life for patients using cutting edge technology and custom-fitted solutions speaks to their commitment to changing the face of drugs.
Media Contact
Name
Protheragen-ING
Contact name
Amy George
State
New York
Country
United States
Url
https://www.protheragen-ing.com/
